Publications
- Fatal Myelotoxicity After Azathioprine treatment2008 | First Faculty of Medicine
- 6-thioguanine therapy on patients intolerant or refractory to azathioprine or 6-mercaptopurine therapy (1)Publication without faculty affiliation
- 6-thioguanine therapy on patients intolerant or refractory to azathioprine or 6-mercaptopurine therapy (2)Publication without faculty affiliation
- 6-thioguanine therapy on patients intolerant or refractory to azathioprine or 6-mercaptopurine therapy (3)Publication without faculty affiliation
- 6-thioguanine therapy on patients intolerant or refractory to azathioprine or 6-mercaptopurine therapyPublication without faculty affiliation
- Recommendations of the Working Group for IBD for the Diagnosis and Drug Treatment of Ulcerative Colitis2022 | Central Library of Charles University, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Safety of vedolizumab and ustekinumab in the treatment of pregnant women with inflammatory bowel disease - a multicentre retrospective-prospective observational study2022 | Central Library of Charles University, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study2022 | Central Library of Charles University, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis-Results of a Randomized Controlled Trial2021 | Central Library of Charles University, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study2021 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...